跳至主要内容
临床试验/NCT03974438
NCT03974438已完成不适用

Acupuncture (Dry-needling) as Treatment of Post-herpetic Neuralgia: A Double-blinded Randomized Clinical Trial.

Odense University Hospital2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2019年9月19日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
40
试验地点
2
主要终点
Dermal pain [LEVEL OF PAIN]

研究概览

简要总结

The aim of this study is to perform the first RCT investigating the possible effect of superficial dry-needling (SDN) - a special kind of acupuncture used for PHN. The participants will be divided into two groups. Group A, the intervention group will receive SDN in the area of pain. Group B, the control group will receive a sham procedure.

详细描述

The aim of this study is to investigate the possible effect of SDN on PHN. The study population consists of patients with chronic pain after herpes zoster.

The study is a controlled double-blinded randomized study. The participants will be divided into two groups, group A, the intervention group, will receive SDN in the area of pain. Group B, the control group will receive a sham procedure. The procedure will take place at the out-patient clinic at Odense University Hospital. The plan is to include 40 patients (20 in each group).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

盲法说明

Participants will not be aware of the treatment given. The randomization will take place right before the procedure begins. The treatment will be given to the skin covering the spine and the patients will be placed in the supine position. They will therefore not know whether or not they are receiving the actual acupuncture or the sham procedure.

The investigator will not be present at the procedures and will not have access to patients records and data until after the trial is complete.

The outcomes are measured using validated questionnaires. They will be assessed by the investigator at the time of project completion.

入排标准

年龄范围
55 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age between 50-75 years.
  • Pain in the dermatomal area of the previous outbreak of HZ.
  • Pain located to a dermatome originating from the thoracic or lumbar spine.
  • At least six months since the outbreak.
  • Understands the purpose of the study and is able to give consent.

排除标准

  • A psychiatric illness affecting participation in the study.
  • Active cancer
  • Pregnancy

结局指标

主要结局

Dermal pain [LEVEL OF PAIN]

时间窗: 1 month

Questionnaire. Visual Analogue Scale (VAS). Patients will be asked to report on their average and maximum level of pain on a scale from 0-10.

次要结局

  • Neuropathic pain [LEVEL OF PAIN](1 month)
  • Quality of life [QUALITY OF LIFE/ SATISFACTION](1 month)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Martin Sollie

Principal investigator, M.D, Dept. of Plastic and Reconstructive Surgery Affiliation: Odense University Hospital Collaborators:

Odense University Hospital

研究点 (2)

Loading locations...

相似试验